CERo Therapeutics Holdings (CERo Therapeutics Holdings) Price-to-Free-Cash-Flow : (As of May. 26, 2024)

View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Price-to-Free-Cash-Flow?

As of today (2024-05-26), CERo Therapeutics Holdings's share price is $0.9178. CERo Therapeutics Holdings does not have enough years/quarters to calculate the Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2022. Therefore GuruFocus does not calculate Price-to-Free-Cash-Flow Ratio at this moment.

The historical rank and industry rank for CERo Therapeutics Holdings's Price-to-Free-Cash-Flow or its related term are showing as below:

CERO's Price-to-Free-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 31.69
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

CERo Therapeutics Holdings's Free Cash Flow per Share for the six months ended in Dec. 2022 was $-1.21.

CERo Therapeutics Holdings Price-to-Free-Cash-Flow Historical Data

The historical data trend for CERo Therapeutics Holdings's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Price-to-Free-Cash-Flow Chart

CERo Therapeutics Holdings Annual Data

Trend

Dec21

Dec22

Price-to-Free-Cash-Flow

CERo Therapeutics Holdings Semi-Annual Data
	Dec21	Dec22
Price-to-Free-Cash-Flow	-	-

Competitive Comparison of CERo Therapeutics Holdings's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, CERo Therapeutics Holdings's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CERo Therapeutics Holdings's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CERo Therapeutics Holdings's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where CERo Therapeutics Holdings's Price-to-Free-Cash-Flow falls into.

CERo Therapeutics Holdings Price-to-Free-Cash-Flow Calculation

CERo Therapeutics Holdings's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio	=	Share Price	/	Free Cash Flow per Share (TTM)
	=	0.9178	/
	=

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio

Market Cap

Free Cash Flow

CERo Therapeutics Holdings (NAS:CERO) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

CERo Therapeutics Holdings Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Price-to-Free-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080

Website

https://www.cero.bio

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines

From GuruFocus

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

By Business Wire • 03-07-2024